Certain health conditions affect which birth control options are appropriate, and CDC guidance aims to remove unnecessary medical barriers to getting it (Nguyen et al., 2024). Most women don't need lab tests to start hormonal birth control. A systematic review found no direct evidence on this, but it concluded there's little value in screening women without symptoms for diabetes, high cholesterol or liver disease first, and it warned that unnecessary tests can be a barrier to getting contraception (Tepper et al., 2013).
What Birth Control Can Change
Birth control can:
- Raise the risk of blood clots: combined pills raised it about 3.5 times compared with no pill, from a low starting risk (de Bastos et al., 2014)
- Change blood levels of certain nutrients (Palmery et al., 2013)
- Lower anti-Mullerian hormone (AMH) readings while you're using it, which matters if you're having your ovarian reserve tested (Hariton et al., 2021)
What Guidelines Say About Testing
Blood Pressure
A blood pressure check can matter before combined pills. A second review of case-control studies found that women who didn't have their blood pressure measured before starting combined pills had a higher risk of heart attack and ischemic stroke than women who did (Tepper et al., 2013).
Blood Clot Risk
The American Society of Hematology strongly recommends against testing the general population for clotting disorders, such as Factor V Leiden or a prothrombin gene mutation, before starting combined pills. It suggests testing in narrower cases, such as a family history of antithrombin, protein C or protein S deficiency (Middeldorp et al., 2023). If you or a close relative has had a blood clot, tell your clinician before you choose a method. After starting a combined pill, get emergency care for sudden chest pain, trouble breathing, pain or swelling in one leg, or a sudden severe headache.
Nutrient Levels
A review reported lower levels of folic acid, vitamins B2, B6, B12, C and E, and magnesium, selenium and zinc in women taking birth control pills (Palmery et al., 2013). If you're worried about your diet, ask your clinician whether any testing makes sense for you.
Thyroid
Starting birth control isn't by itself a reason for a thyroid test. Screening for hypothyroidism isn't recommended for people without symptoms (Chaker et al., 2025). If you have symptoms such as fatigue, weight gain or changes in your periods, ask your clinician about a TSH test.
Metabolic
Some hormonal methods may not be safe for some women with diabetes, high cholesterol or liver disease. But these conditions are uncommon at reproductive age, so the review on lab screening concluded there's little value in screening women without symptoms before starting (Tepper et al., 2013). If you already have one of them, tell your clinician.
Special Considerations
CDC guidance sets out which methods suit people with specific conditions (Nguyen et al., 2024). Tell your clinician if you have:
- Migraines with aura, since the CDC recommends avoiding combined pills (Paradise et al., 2022)
- High blood pressure, or if you smoke and are older than 35 (Lauring et al., 2016)
- A history of blood clots
- Certain heart conditions
- Liver disease
- A history of breast cancer
References
- Palmery, M., et al. (2013). Oral contraceptives and changes in nutritional requirements. European Review for Medical and Pharmacological Sciences, 17(13), 1804-1813. PMID 23852908
- Nguyen, A. T., et al. (2024). U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. MMWR. Recommendations and Reports, 73(4), 1-126. PMID 39106314
- Tepper, N. K., et al. (2013). Laboratory screening prior to initiating contraception: a systematic review. Contraception, 87(5), 645-649. PMID 23040133
- Tepper, N. K., et al. (2013). Blood pressure measurement prior to initiating hormonal contraception: a systematic review. Contraception, 87(5), 631-638. PMID 23063336
- de Bastos, M., et al. (2014). Combined oral contraceptives: venous thrombosis. Cochrane Database of Systematic Reviews, 2014(3), CD010813. PMID 24590565
- Hariton, E., et al. (2021). Anti-Müllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals. American Journal of Obstetrics and Gynecology, 225(5), 515.e1-515.e10. PMID 34126087
- Middeldorp, S., et al. (2023). American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Advances, 7(22), 7101-7138. PMID 37195076
- Chaker, L., et al. (2025). Hypothyroidism: A Review. JAMA, 334(19), 1750-1760. PMID 40900603
- Paradise, S. L., et al. (2022). Evidence-Based Contraception: Common Questions and Answers. American Family Physician, 106(3), 251-259. PMID 36126006
- Lauring, J. R., et al. (2016). Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use. American Journal of Obstetrics and Gynecology, 215(3), 330.e1-7. PMID 27059507



